ContraFect Corporation
ContraFect Corporation (CFRXQ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CFRXQ · as of Jun 8, 2026
Key Statistics
Explore ContraFect Corporation Data
cfrxq stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
cfrxq competitorsCFRXQ
ADYX
BIMI
DMKPQ
EFTR
GRPIStock Performance
Full HistoryAbout ContraFect Corporation
ContraFect Corporation a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious dis…
what is contrafect corporation · cfrxq stock overview · contrafect corporation company profile · who is contrafect corporation ceo · cfrxq OTC · contrafect corporation headquarters · contrafect corporation business segments
About Stock Overview & Key Data
ContraFect Corporation (CFRXQ) is a Healthcare company in the Biotechnology industry, listed on OTC since Sep 12, 2014. As of the latest trading session, CFRXQ stock price is $0.00, with a market capitalization of $107. The stock has returned -90.00% over the past 12 months and +0.00% year-to-date.
According to 1 Wall Street analysts, the consensus rating for ContraFect Corporation stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, ContraFect Corporation reported revenue of — and net income of -$65.2M. For detailed data — including ContraFect Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, ContraFect Corporation (CFRXQ) stock price is $0.00. The stock is traded on OTC under the ticker symbol CFRXQ. The 52-week range is $0.00 – $0.00.